COLORECTAL CANCER SCREENING PROGRAMME

Reporting year for qualitative data:	2020
Source of qualitative data:	Directly from Programme

Organization of screening
An individual/team/institution responsible to coordinate the programme:	Yes
Dedicated budget for screening programme:	Yes
Documented cancer screening policy:	Yes
Nature of documentation of the policy:	Notification
Year programme was initiated:	2009
Programme introduction was preceded by a pilot:	Yes, pilot evaluated and report published
Screening tests provided free of charge:	Yes
Diagnostic tests provided free of charge:	Yes
Treatment services provided free of charge:	Yes
Information system and data collection
System that collects data:	Individual & Aggregated
• Identification of eligible population:	Individual
• Screening participation:	Individual & Aggregated
• Screening test results:	Individual & Aggregated
• Further assessment:	Individual & Aggregated
• Final pathology diagnosis:	Individual & Aggregated
• Cancer staging:	Individual & Aggregated
• Treatment:	Individual & Aggregated
The information system exists at national or sub-national level:	Individual: Sub-national Aggregated: Sub-national
The information system collects data outside the programme (opportunistic screening/private sector):	Yes
Cancer screening data is linked with population-based cancer registry (PBCR):	Yes
Screening protocol
A screening protocol or guideline:	Yes
Year of published/updated protocol:	2017
Target age (min-max) and screening interval [months] for each test:	FIT (50-69 years / [24 months])
Invitations for screening and further assessment
Initiatives to create population awareness by the Health Ministry/Health Authority:	Mass media campaign Small media campaign Group education One-on-one education Dedicated website
Invitations to eligible population:	Yes
Source of the eligible individuals identified:	Population register Electorall roll Other
Method of invitation:	Letter
Screening kit included with the invitation:	Yes
Screen positive individuals actively contacted for further assessment:	Yes
Individuals with a precancer or cancer diagnosis actively contacted:	Yes
Quality Assurance (QA) of screening activities
Documented standard operating procedure/policy for QA:	Yes
An individual/team/institution responsible for QA:	Yes
Accreditation of endoscopy units:	No
Accreditation of pathology services:	No
Documented performance indicators:	Yes
Reference standards for performance indicators:	Yes
Evaluation reports published in the last five years:	Yes
Sub-national data is available for:    • Basque Country (2020)
Performance indicators
Reporting year for quantitative data:	2016
Source of quantitative data:	Report (EU Report 2017)

	FIT	gFOBT	Sigmoidoscopy	Colonoscopy
Target age and regional limitation if applicable:	50-74
Invitation coverage (%):	16.4
Participation rate (%):	52.2
Examination coverage (%):	8.6
Completeness of data related to screening results (%):	99.8
Completeness of data related to information about attendance to colonoscopy assessment (%):	100.0
Further assessment (diagnosis colonoscopy) rate (%):	6.7
Further assessment participation rate (%):	90.7
Detection rate of adenomas (x 1000):	33.3
Detection rate of advanced adenomas (x 1000):	22.8
Detection rate of colorectal cancers (x 1000):	2.9
Positive Predictive Value of further assessment to detect adenomas (%):	55.2
Positive Predictive Value of further assessment to detect advanced adenomas (%):	37.8
Positive Predictive Value of further assessment to detect colorectal cancers (%):	4.9
More quantitative data (Male - 2013/FIT)
More quantitative data (Women - 2013/FIT)
More quantitative data (Basque Country: Male - 2018/FIT)
More quantitative data (Basque Country: Women - 2018/FIT)

Check also the following factsheets: Spain, Breast, Cervical